Hypo-Fit gains Drug Tariff approval

Hypo-Fit, a glucose syrup, has gained Drug Tariff approval and may be prescribed at NHS expense for the treatment of hypoglycaemia.

Hypo-Fit is presented in 18g sachets, making it easily portable for patients with diabetes who may become hypoglycaemic. Hypo-Fit is presented in packs of 12, containing individual flavours (orange, tropical or mint) or four of each flavour, at a cost of £13.50.

Further information: Arctic Medical Ltd, Ingles Manor, Castle Hill Avenue, Folkestone, Kent CT20 2RD. Tel: (01303) 850856.
Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Two new steroid inhalers launched

Two new steroid inhalers launched

A new beclometasone metered-dose inhaler and a new...

Half of patients on statins do not reach cholesterol goals, study shows

Half of patients on statins do not reach cholesterol goals, study shows

Half of patients prescribed statins fail to reach their...

First oral hypoglycaemic licensed for add-on therapy in type I diabetes

First oral hypoglycaemic licensed for add-on therapy in type I diabetes

The SGLT2 inhibitor dapagliflozin (Forxiga) can now...

Quick-reference MIMS COPD prescribing resources updated

Quick-reference MIMS COPD prescribing resources updated

Concise MIMS resources on COPD management and antibiotic...